FDA Approves the First New Schizophrenia Drug in Decades
Developed by Karuna Therapeutics, which was subsequently acquired by Bristol Myers Squibb, the drug works in an entirely ...
studyfinds9d
Alzheimer’s drug breakthrough or breakdown? Investigation exposes red flags in FDA approval of donanemab
A startling investigation has revealed a troubling story behind donanemab's approval -- one of questionable data, potential ...
FDA approves new schizophrenia drug
The U.S. Food and Drug Administration has approved a new drug for adults with schizophrenia,  the FDA announced Thursday.
Critical Flaws: New Alzheimer’s Drug Could Actually Be a Safety Risk
An investigation has uncovered alarming issues including increased mortality rates, absent safety records, dubious efficacy, ...
BMJ10d
Donanemab: Conflicts of interest found in FDA committee that approved new Alzheimer’s drug
A new drug for Alzheimer’s disease is causing excitement despite excess deaths, missing safety data, questionable efficacy, and financial conflicts of interest among the “independent” advisory ...
The Washington Post on MSN9d
FDA approves a novel drug for schizophrenia, a potential ‘game changer’
The U.S. Food and Drug Administration ... the agency approved Cobenfy without a “black box” warning on the regulatory label ...
US FDA approves IntraBio's drug for rare genetic disease
Niemann-Pick disease type C (NPC) is a rare genetic disorder that affects the nervous system and other organs, causing ...
i10d
Alzheimer’s ‘wonder drug’ was approved by scientists funded by pharma firm
A BMJ investigation found seven of the eight doctors appointed by the US Food & Drug Administration (FDA) to review donanemab ...
News Medical on MSN10d
Alzheimer’s Drug Faces Scrutiny Over Safety, Efficacy Concerns
The FDA-approved Alzheimer’s drug donanemab is under scrutiny due to concerns about its effectiveness and safety, according to an investigation.
technologynetworks5d
The Evolving Treatment Landscape for Alzheimer’s
We spoke to Andrew Doig, professor of biochemistry at the University of Manchester, to find out more about the evolving ...
ABC News9d
FDA approves 1st new drug for schizophrenia in more than 30 years
The medication, Cobenfy, combines two drugs and is taken as a twice-daily pill. The U.S. Food and Drug Administration (FDA) on Thursday ... including the treatment of Alzheimer's disease and ...